Calidi Biotherapeutics, Inc. (CLDI): insider trading, Congress trades & who owns it

Insider signal
50/100
Neutral · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$1K
1 seller · 12 months
Funds holding
23
13F · Q2 2026
Congress trades
None
none in 2 years

Insider activity at Calidi Biotherapeutics, Inc. has been all selling for a year now: about $1,241 from one seller, and zero buyers with their own money.

Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.

Big money check: 23 institutions held CLDI as of Q2 2026, and more funds bought than sold. No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.

Want the full picture on CLDI? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full CLDI report — free account

Latest insider trades in CLDI

FiledInsiderRoleTypeSharesPriceValueSource
Dec 16, 2025Camaisa AllanDirectorSell850$1.46$1KSEC
Aug 25, 2025Jackson Andrew C.CFOBuy2,500$2.00$5KSEC
Aug 25, 2025Leftwich ScottDirectorBuy125,000$2.00$250KSEC
Aug 25, 2025Poma Eric ECEOBuy25,000$2.00$50KSEC
Aug 25, 2025Schoeneck James ADirectorBuy75,000$2.00$150KSEC
Dec 18, 2024Camaisa AllanCEOSell10,000$1.62$16KSEC

Questions about CLDI

Are insiders buying or selling CLDI stock?

In the last 12 months Calidi Biotherapeutics, Inc. insiders made open-market purchases worth about $0 and sales worth about $1,241. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

When was the last insider trade in CLDI?

The most recent open-market insider trade in CLDI was filed on 2025-12-16.

How many institutions own CLDI?

23 investment managers reported holding CLDI in SEC Form 13F filings for Q2 2026.

Has any member of Congress traded CLDI?

No congressional trades in CLDI were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).